DEERFIELD, Ill. – The Leukemia & Lymphoma Society and Walgreens on Wednesday announced the launch of a collaboration created to further arrive cancer therapies and treat the changing treatment model facing patients along with blood and various other cancers.
“We are proud to group up along with LLS on this transformational approach to empowering and supporting patients through our expert oncology specialized pharmacies across the country,” mentioned Richard Ashworth, president, pharmacy and retail operations for Walgreens. “along with our aligned missions and commitment to serving patients and families, LLS and Walgreens will certainly make an also higher impact on the healthiness and care of the nearly 1.2 million people in the U.S. living along with or in remission from a blood cancer.”
As brand-new blood cancer therapies come to market and patients are able to regulate their ailment along with oral medications at home, Walgreens Specialty Pharmacy pharmacists are well-placed on the front lines of patient care to tips promote this treatment transition and play a substantial role in providing access to these brand-new therapies.
This collaboration will certainly tips patients, families and caregivers in 3 essential ways:
- Provide educational tools and resources for enhanced patient support;
- Implement a pharmacist education and training regimen to make sure pharmacists are knowledgeable concerning aspects of the cancer care continuum and can easily Give added care; and
- Advocate for community engagement and corporate sustain for LLS’s iconic Light The Night Walk national fundraising campaign.
“Today, brand-new treatments for blood cancers are entering the healthcare arena at an unprecedented rate. And these treatments are extending patients’ lives by years, also decades,” noted Louis DeGennaro, LLS president and CEO. “Our collaboration along with industry leader, Walgreens Specialty Pharmacy, assures that patients and their caregivers have actually timely access to high-quality, up-to-date write-up to finest regulate their disease.”
LLS has actually played a role in a substantial variety of the treatments that have actually been created for blood cancers. In fact, due to the fact that 2000 much more compared to 40% of brand-new cancer therapies approved by the Meals and Drug Administration were very first approved to handle blood cancer patients. And, lots of of these treatments are now being used properly to handle various other cancers and chronic diseases.
As portion of the healthcare sustain group serving blood cancer patients, LLS will certainly delivering to Walgreens its know-how as a top global source of write-up for blood cancer patients along with educational services to increase pharmacist degree of care and enhance outcomes.
And through LLS’s write-up source Center, Walgreens and LLS can easily tips Walgreens blood cancer patients across the country access quality, affordable, coordinated care. Staffed by master’s degree-degree healthcare specialists, LLS’s IRC currently responds to over 60,000 annual inquiries from patients, caregivers and healthiness care professionals in reason of help about treatments, supportive care, financial sustain and clinical trials. Walgreens patients will certainly have actually unique access to a dedicated healthcare specialist.
LLS additionally has actually set its leadership along with a collection of comprehensive blood cancer conferences – attended by thousands of patients and caregivers at no charge. As a national sponsor of these educational conferences, Walgreens pharmacy experts will certainly interact along with patients straight in their communities, alongside LLS, to Give the most recent write-up concerning ailment and treatment breakthroughs.
Walgreens has actually been a longstanding supporter of LLS and is currently the tenth largest LLS Light The Night Walk group in the U.S. Walgreens intends to accelerate this sustain and strengthen relationships within cancer communities.
